Viewing Study NCT04884269


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2025-12-25 @ 8:27 PM
Study NCT ID: NCT04884269
Status: COMPLETED
Last Update Posted: 2024-02-15
First Post: 2021-05-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Non Interventional Pilot Study on Machine Learning for ILD Detection Based on the Patient Data From Digital Devices in Unresectable Stage III Non-Small Cell Lung Cancer Patients Receiving Durvalumab
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-08-11
Start Date Type: ACTUAL
Primary Completion Date: 2023-03-03
Primary Completion Date Type: ACTUAL
Completion Date: 2023-03-03
Completion Date Type: ACTUAL
First Submit Date: 2021-05-11
First Submit QC Date: None
Study First Post Date: 2021-05-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-02-14
Last Update Post Date: 2024-02-15
Last Update Post Date Type: ACTUAL